Invention Grant
- Patent Title: Salt forms of URAT-1 inhibitors
-
Application No.: US17041855Application Date: 2019-03-26
-
Publication No.: US11339127B2Publication Date: 2022-05-24
- Inventor: Xing Dai , Yueheng Jiang
- Applicant: INVENTISBIO SHANGHAI LTD.
- Applicant Address: CN Shanghai
- Assignee: INVENTISBIO SHANGHAI LTD.
- Current Assignee: INVENTISBIO SHANGHAI LTD.
- Current Assignee Address: CN Shanghai
- Agency: Nixon & Vanderhye P.C.
- Priority: WOPCT/CN2018/080889 20180328
- International Application: PCT/CN2019/079619 WO 20190326
- International Announcement: WO2019/184897 WO 20191003
- Main IPC: C07D213/70
- IPC: C07D213/70 ; A61K31/426 ; A61K31/522 ; A61K31/4418

Abstract:
Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to thiobutyrate compounds, such as Compound (1) and its salts (such as sodium, potassium, and calcium salt), as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, crystalline forms, and pharmaceutical compositions for the treatment of diseases or disorders, such as gout and hyperuricemia.
Public/Granted literature
- US20210032204A1 NOVEL SALT FORMS OF URAT-1 INHIBITORS Public/Granted day:2021-02-04
Information query